Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-09-27
2008-12-30
Landsman, Robert (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C435S004000, C435S007100, C530S324000
Reexamination Certificate
active
07470669
ABSTRACT:
The present invention is drawn to methods of screening for new compounds for the treatment of obesity and obesity-related diseases and disorders, as well as methods of treating obesity-related diseases and disorders, based on the discovery of the role of the leptin-LSR interaction in obesity.
REFERENCES:
patent: 5827734 (1998-10-01), Weigle et al.
patent: 5935810 (1999-08-01), Friedman et al.
patent: 6344441 (2002-02-01), Bihain et al.
patent: 6635431 (2003-10-01), Bihain et al.
patent: 2767135 (1999-02-01), None
patent: WO 96/30400 (1996-10-01), None
patent: WO 96/39429 (1996-12-01), None
patent: WO 97/06816 (1997-02-01), None
patent: WO 97/46585 (1997-12-01), None
patent: WO 98/12224 (1998-03-01), None
Verploegen et al., FEBS Letters 405, 237-240, 1997.
Mickle et al., Med. Clin. North Am., 2000, vol. 84(3), p. 597-607.
Grasso et al., Endocrinol. 138: 1413-1418, 1997.
Rohner-Jearnrenaud et al., The New Eng. J. Med., 334: 324-325, 1996.
Campfield et al., Science 280: 1383-1387, 1998.
Baskin, D.G. et al. “Leptin Receptor mRNA Identifies a Subpopulation of Neuropeptide Y Neurons Activated By Fasting in Ray Hypothalamus”Diabetes,Apr. 1999, pp. 828-833, vol. 48.
Bays, H. “Current and Investigational Antiobesity Agents and Obesity Therapeutic Treatment Targets”Obesity Research,Aug. 2004, pp. 1197-1210, vol. 12, No. 8.
Bihain, B.E. et al. “The Lipolysis Stimulated Receptor: A Gene at Last”Curr. Opinion in Lip.,Jun. 1998, pp. 221-224, vol. 9, No. 3.
Campfield, L.A. et al. “Recombinant Mouse OB Protein: Evidence for a Peripheral Signal Linking Adiposity and Central Neural Networks”Science,1995, pp. 546-549, vol. 269, No. 5223.
Cheung, C.C. et al. “Proopiomelanocortin Neurons are Directed Targets for Leptin in the Hypothalamus”Endocrinology,1997, pp. 4489-4492, vol. 138, No. 10.
Considine, R.V. et al. “Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans”New Eng. J. Med,Feb. 1, 1996, pp. 292-295, vol. 334.
Ghebrehiwet, B. et al. “Isolation, cDNA Cloning and Overexpression of a 33-kD Cell Surface Glycoprotein that binds to the Globular ‘Heads’ of C1q”J. Exp. Med., Jun. 1994, pp. 1809-1821, vol. 179, The Rockefeller University Press.
Hayward, C.P.M. et al. “The cDNA Sequence of Human Endothelial Cell Multimerin”J. Biol. Chem., Aug. 4, 1995, pp. 18246-18251, vol. 270, No. 31.
Hu, E. et al. “AdipoQ is a Novel Adipose-Specific Gene Dysregulated in Obesity”J. Biol. Chem., May 3, 1996, pp. 10697-10703, vol. 271, No. 18.
Kopelman, P.G. “Obesity as a Medical Problem”Nature, Apr. 6, 2000, pp. 635-643, vol. 404.
Maeda, K. et al. “cDNA Cloning and Expression of a Novel Adipose Specific Collagen-Like Factor, apM1 (Adipose Most Abundant Gene Transcript 1)”Biochem. and Biophys. Research Comm.,1996, pp. 286-289, vol. 221.
Mann, C.J. et al. “Mechanism of Activation and Functional Significance of the Lipolysis-Stimulated Receptor. Evidence for a Role as Chylomicron Remnant Receptor”Biochemistry,1995, pp. 10421-10431, vol. 34, No. 33.
Mann, C.J. et al. “ApoCIII Inhibits the Binding of Triglyceride-Rich Lipoproteins to the Lipolysis Stimulated Receptor”Inserm Unit 391, 1996, Rennes, France, abstract only.
Schwartz, M.W. et al. “Central Nervous System Control of Food Intake”Nature,Apr. 6, 2000, pp. 661-671, vol. 404.
Schwartz, M.W. et al. “Cerebrospinal Fluid Leptin Levels: Relationship to Plasma Levels and to Adiposity in Humans”Nature Med.,May 1, 1996, pp. 589-593, vol. 2.
Sellar, C.G. et al. “Characterization and Organization of the Genes Encoding the A-, B- and C-Chains of Human Complement Subcomponent C1q. The Complete Derived Amino Acid Sequence of Human C1q”Biochemical Journal,1991, pp. 481-490, vol. 274.
Troussard, A.A. et al. “Inhibitory Effect on the Lipolysis-Stimulated Receptor of the 39-kDa Receptor-Associated Protein”J. Biol. Chem.,Jul. 21, 1995, pp. 17068-17071, vol. 270, No. 29.
Urade, Y. et al. “Precerebellin is a Cerebellum-Specific Protein with Similarity to the Globular Domain of Complement C1q B Chain”Proc. Natl. Sci. USA,Feb. 1991, pp. 1069-1073, vol. 88.
Weigle, D.S. et al. “Recombinant OB Protein Reduces Feeding and Body Weight in the OB/OB Mouse”J. Clin. Invest,Oct. 1995, pp. 2065-2070, vol. 96, No. 4.
Zhang, Y. et al. “Positional Cloning of the Mouse Obese Gene and Its Human Homologue”Nature,1994, pp. 425-432, vol. 372.
Bihain Bernard
Erickson Mary Ruth
Fruebis Joachim
Yen Frances
Chandra Gyan
Landsman Robert
Saliwanchik Lloyd & Saliwanchik
Serono Genetics Institute S.A.
LandOfFree
Isolated polypeptide comprising a leptin fragment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated polypeptide comprising a leptin fragment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated polypeptide comprising a leptin fragment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4024234